Allogene Therapeutics Inc (ALLO)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.5400 -0.0300 (-1.91%) 04/29/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.5004 -0.0396 (-2.57%) 17:25 ET
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select Fields| Symbol | ALLO | CKPT | OLMA | ||
| Company | Allogene Therapeutics Inc | Checkpoint Therapeutics Inc | Olema Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.5700 | 4.11 | 4.89 | ||
| High | 1.6400 | 4.11 | 5.15 | ||
| Low | 1.4900 | 4.09 | 4.85 | ||
| Last | 1.5400 | 4.10 | 5.04 | ||
| Change | -0.0300 | -0.01 | +0.15 | ||
| % Change | -1.91% | -0.24% | +3.07% | ||
| Volume | 2,276,000 | 920,500 | 513,800 | ||
| 20-Day Average Volume | 2,592,200 | 1,778,545 | 1,052,015 | ||
| Previous Close | 1.5700 | 4.11 | 4.89 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.4625 | 4.03 | 4.07 | ||
| 20-Day Raw Stochastic | 59.62% | 84.21% | 91.21% | ||
| 20-Day Relative Strength | 47.31% | 63.03% | 60.32% | ||
| Weighted Alpha | -58.06 | +56.49 | -45.22 | ||
| Today's Opinion | 88% Sell | 100% Buy | 56% Sell | ||
| Previous Opinion | 88% Sell | 100% Buy | 56% Sell | ||
| Last Month's Opinion | 100% Sell | 88% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.14% since 04/22/25 | +1.49% since 04/22/25 | +1.61% since 04/22/25 | ||
| Low | 1.4900 on 04/29/25 | 4.04 on 04/23/25 | 4.66 on 04/28/25 | ||
| High | 1.7500 on 04/23/25 | 4.13 on 04/28/25 | 5.25 on 04/23/25 | ||
| 1-Month | |||||
| %Chg | -0.65% since 03/28/25 | +1.49% since 03/28/25 | +22.63% since 03/28/25 | ||
| Low | 1.2300 on 04/09/25 | 3.94 on 04/09/25 | 2.86 on 04/07/25 | ||
| High | 1.7500 on 04/23/25 | 4.13 on 04/28/25 | 5.25 on 04/23/25 | ||
| 3-Month | |||||
| %Chg | -16.30% since 01/29/25 | +44.37% since 01/29/25 | -18.84% since 01/29/25 | ||
| Low | 1.2300 on 04/09/25 | 2.37 on 03/07/25 | 2.86 on 04/07/25 | ||
| High | 3.7800 on 02/19/25 | 4.13 on 04/28/25 | 6.70 on 02/05/25 | ||
| 6-Month | |||||
| %Chg | -45.00% since 10/29/24 | +6.77% since 10/29/24 | -57.50% since 10/29/24 | ||
| Low | 1.2300 on 04/09/25 | 2.37 on 03/07/25 | 2.86 on 04/07/25 | ||
| High | 3.7800 on 02/19/25 | 4.50 on 12/02/24 | 13.51 on 11/06/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 341,106 | 344,270 | 334,148 | ||
| Shares Outstanding, K | 217,265 | 83,764 | 68,333 | ||
| Annual Sales | 20,000 | 40,000 | 0 | ||
| Annual Net Income | -257,590,000 | -56,240,000 | -129,470,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -59,940,000 | -9,730,000 | -33,570,000 | ||
| 60-Month Beta | 0.99 | 1.21 | 2.10 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.28 on 03/13/25 | -0.69 on 03/28/25 | -0.51 on 03/18/25 | ||
| Latest Earnings Date | 05/12/25 | 05/09/25 | 05/14/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||